Literature DB >> 6811452

Lesions of the facial and trigeminal nerve in leprosy. An evaluation of 43 cases.

P A Reichart, S Srisuwan, D Metah.   

Abstract

Facial and trigeminal nerve involvement was studied in 43 leprosy patients, 5.7% of the 750 Thai national in-patients of a leprosy rehabilitation centre. Involvement of the facial nerve occurred late in the disease and had an average duration of 12.1 years. The zygomatic branches of this nerve were the most frequently affected. Hypaesthesia and anaesthesia were most often observed in the maxillary divisions. Periorbital surgical procedures to prevent severe ocular complications are evaluated and discussed.

Entities:  

Mesh:

Year:  1982        PMID: 6811452     DOI: 10.1016/s0300-9785(82)80043-4

Source DB:  PubMed          Journal:  Int J Oral Surg        ISSN: 0300-9785


  5 in total

1.  Supraorbital nerve entrapment neuropathy in Hansen's disease.

Authors:  Sergio Gennaro; Francesca Secci; Pietro Fiaschi; Paolo Merciadri
Journal:  Neurol Sci       Date:  2013-07-16       Impact factor: 3.307

2.  Incomplete peripheral facial nerve palsy and ulnar neuropathy due to leprosy mistaken as faciobrachial stroke.

Authors:  Rakesh Lalla; Rupal Vijay Mulherkar; Parag Vijay Misar
Journal:  BMJ Case Rep       Date:  2015-06-23

3.  High oral prevalence of Candida krusei in leprosy patients in northern Thailand.

Authors:  P A Reichart; L P Samaranayake; Y H Samaranayake; M Grote; E Pow; B Cheung
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Detection of Mycobacterium leprae in saliva and the evaluation of oral sensitivity in patients with leprosy.

Authors:  Fernanda Borowsky da Rosa; Victor Costa de Souza; Tatiana Amaral Pires de Almeida; Valdinete Alves do Nascimento; Felicien Gonçalves Vásquez; Maria da Graça Souza Cunha; Felipe Gomes Naveca
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-08       Impact factor: 2.743

5.  Trigeminal trophic syndrome.

Authors:  Parimalam Kumar; Jayakar Thomas
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.